Anna Bläckberg
Impact in
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
-
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 5
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Bacterial Identification and Susceptibility Testing 11
- Co-authors
- Magnus Rasmussen (13 shared papers)Torgny Sunnerhagen (10 shared papers)Lars Olaison (3 shared papers)Bo Nilson (4 shared papers)Rolf Lood (2 shared papers)Gizem Ertürk (1 shared paper)Fredrik Kahn (3 shared papers)Andreas Berge (2 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Infectious Diseases (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)Nature Communications (1 paper)
- Partner nations
- SwedenSwitzerlandThailand
In The Last Decade
Anna Bläckberg
21 papers receiving 247 citations
Peers
Comparison fields: 5 of 69
- Clinical Biochemistry 59
- Infectious Diseases 107
- Endocrinology 26
- Applied Microbiology and Biotechnology 9
- Public Health, Environmental and Occupational Health 86
Countries citing papers authored by Anna Bläckberg
This map shows the geographic impact of Anna Bläckberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bläckberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bläckberg more than expected).
Fields of papers citing papers by Anna Bläckberg
This network shows the impact of papers produced by Anna Bläckberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bläckberg. The network helps show where Anna Bläckberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Bläckberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 51 | |
| 2 | 2019 | 39 | |
| 3 | 2020 | 21 | |
| 4 | 2021 | 19 | |
| 5 | 2021 | 16 | |
| 6 | 2018 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2024 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2021 | 2 |
About Anna Bläckberg
Anna Bläckberg is a scholar working on Infectious Diseases, Clinical Biochemistry, Public Health, Environmental and Occupational Health, Epidemiology and Endocrinology, having authored 21 papers that have together received 253 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (11 papers), Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Infective Endocarditis Diagnosis and Management (4 papers), COVID-19 Clinical Research Studies (3 papers), Neonatal and Maternal Infections (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Salmonella and Campylobacter epidemiology (2 papers). The work is most often cited by research in Clinical Biochemistry (59 citations), Infectious Diseases (107 citations), Endocrinology (26 citations), Applied Microbiology and Biotechnology (9 citations) and Public Health, Environmental and Occupational Health (86 citations). Anna Bläckberg has collaborated with scholars based in Sweden, Switzerland and Thailand. Frequent co-authors include Magnus Rasmussen, Torgny Sunnerhagen, Lars Olaison, Bo Nilson, Rolf Lood, Gizem Ertürk, Fredrik Kahn, Andreas Berge, Volkan Özenci and Per Åkesson. Their work appears in journals such as Open Forum Infectious Diseases, Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Infectious Diseases and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.